Journal article

Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: An australian multicenter cohort study

G Mishra, A Dev, E Paul, W Kemp, A Majeed, J Lubel, S Bell, P Gow, A Nicoll, S Sood, A Thompson, M Ryan, SK Roberts

Hepatoma Research | Published : 2021


Aim: Transarterial chemoembolisation (TACE) is recommended therapy for intermediate-stage hepatocellular carcinoma (HCC). However, the wide variations in outcomes reflect significant heterogeneity of this patient group. We evaluated the prognostic factors associated with survival in a real-world setting to identify those at high risk of a poor outcome. Methods: Patients with HCC who underwent initial TACE at six tertiary hospitals between 2009 to 2014 were included via an extensive search of hospital databases and electronic medical records. Overall survival (OS) was measured from the date of initial treatment to the date of death or last follow-up. Univariate and multivariate Cox regression..

View full abstract